HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Videoscopic left cardiac sympathetic denervation for patients with recurrent ventricular fibrillation/malignant ventricular arrhythmia syndromes besides congenital long-QT syndrome.

AbstractBACKGROUND:
Treatment options for patients with recurrent ventricular arrhythmias refractory to pharmacotherapy and ablation are minimal. Although left cardiac sympathetic denervation (LCSD) is well established in long-QT syndrome, its role in non-long-QT syndrome arrhythmogenic channelopathies and cardiomyopathies is less clear. Here, we report our single-center experience in performing LCSD in this setting.
METHODS AND RESULTS:
In this institutional review board-approved study, we retrospectively reviewed the electronic medical records of all patients (N=91) who had videoscopic LCSD at our institution from 2005 to 2011. Data were analyzed for the subset (n=27) who were denervated for an underlying diagnosis other than autosomal dominant or sporadic long-QT syndrome. The spectrum of arrhythmogenic disease included catecholaminergic polymorphic ventricular tachycardia (n=13), Jervell and Lange-Nielsen syndrome (n=5), idiopathic ventricular fibrillation (n=4), left ventricular noncompaction (n=2), hypertrophic cardiomyopathy (n=1), ischemic cardiomyopathy (n=1), and arrhythmogenic right ventricular cardiomyopathy (n=1). Five patients had LCSD because of high-risk assessment and β-blocker intolerance, none of whom had a sentinel breakthrough cardiac event at early follow-up. Among the remaining 22 previously symptomatic patients who had LCSD as secondary prevention, all had an attenuation in cardiac events, with 18 having no breakthrough cardiac events so far and 4 having experienced ≥1 post-LCSD breakthrough cardiac event.
CONCLUSIONS:
LCSD may represent a substrate-independent antifibrillatory treatment option for patients with life-threatening ventricular arrhythmia syndromes other than long-QT syndrome. The early follow-up seems promising, with a marked reduction in the frequency of cardiac events postdenervation.
AuthorsMira A Coleman, J Martijn Bos, Jonathan N Johnson, Heidi J Owen, Claude Deschamps, Christopher Moir, Michael J Ackerman
JournalCirculation. Arrhythmia and electrophysiology (Circ Arrhythm Electrophysiol) Vol. 5 Issue 4 Pg. 782-8 (Aug 01 2012) ISSN: 1941-3084 [Electronic] United States
PMID22787014 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Topics
  • Adolescent
  • Adult
  • Arrhythmogenic Right Ventricular Dysplasia (physiopathology, surgery)
  • Child
  • Child, Preschool
  • Disease-Free Survival
  • Endoscopy (adverse effects)
  • Female
  • Heart (innervation)
  • Humans
  • Infant
  • Isolated Noncompaction of the Ventricular Myocardium (physiopathology, surgery)
  • Jervell-Lange Nielsen Syndrome (physiopathology, surgery)
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Minnesota
  • Recurrence
  • Retrospective Studies
  • Sympathectomy (adverse effects, methods)
  • Sympathetic Nervous System (physiopathology)
  • Tachycardia, Ventricular (diagnosis, physiopathology, surgery)
  • Time Factors
  • Treatment Outcome
  • Ventricular Fibrillation (diagnosis, physiopathology, surgery)
  • Video-Assisted Surgery (adverse effects)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: